Eli Lilly reported higher profit and raised its outlook on surging demand for its weight-loss drugs, sending its shares ...

Eli Lilly chairman and CEO David Ricks joins CNBC’s “Squawk on the Street” team to discuss its quarterly earnings report that ...

Amy Schumer unveiled her slimmer figure after losing about 40lbs, crediting the weight-loss drug Mounjaro for her ...

Amy Schumer is flaunting her new look after a major weight loss.

The comedian has taken her followers along for the ride as she's experimented with different weight-loss drugs to find what ...

The surgeons were very matter-of-fact when they came to Ellen Ogley’s before her hysterectomy operation. She’d expected some ...

The surgeons were very matter-of-fact when they came to Ellen Ogley’s before her hysterectomy operation. She’d expected some ...

A woman has taken to the internet to share the biggest difference she experienced when switching between GLP-1 drugs Wegovy ...

The instant success of weight loss drugs in India tells us how quickly the country is changing. And for once, the change is ...

Eli Lilly raised its full-year profit and revenue forecast on Thursday as strong appetite for its widely popular weight-loss ...

U.S. sales of Lilly’s weight-loss treatment Zepbound nearly tripled, to $3.57 billion, in the third quarter. Meanwhile, ...

The company sees no supply constraints for tirzepatide, a concern that has plagued other players in the GLP-1 space globally.